Sir Greg Winter, of the University of Cambridge, has been jointly awarded the 2018 Nobel Prize in Chemistry, along with Frances Arnold and George...
Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer’s disease...
A new drug based on decades of research at the University of Cambridge has today been approved by the National Institute for Health and Care...
Approval concludes nearly 40-year epic journey from fundamental research to discovery of an effective treatment for active relapsing multiple...
The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to...
Cambridge neurologists have shown that an antibody used to treat leukaemia also limits and repairs the damage in multiple sclerosis.
